Neurodegenerative Disorders
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases.
|
2140897 |
1990 |
Malignant neoplasm of breast
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Using antisera raised against partially purified rabbit mammary gland prolactin receptor, we have isolated a cDNA from a T-47D human breast cancer cell expression library which encodes the putative calcium-binding protein, calcyclin.
|
2448309 |
1988 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Using antisera raised against partially purified rabbit mammary gland prolactin receptor, we have isolated a cDNA from a T-47D human breast cancer cell expression library which encodes the putative calcium-binding protein, calcyclin.
|
2448309 |
1988 |
Cystic Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Serum concentrations of a granulocyte-derived calcium-binding protein in cystic fibrosis patients and heterozygotes.
|
3436044 |
1987 |
Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In contrast to RD cells that expressed preferentially myoid and not neurofilament proteins (NFPs) upon treatment with UDP-4, differentiated RD/TE-671 cells exhibited characteristic dendritic processes and expressed NFPs (NFP68, NFP160, and NFP200), parvalbumin (calcium-binding protein), and neuron-specific enolase, as well as a small amount of vimentin and desmin.
|
8780893 |
1996 |
Childhood Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In contrast to RD cells that expressed preferentially myoid and not neurofilament proteins (NFPs) upon treatment with UDP-4, differentiated RD/TE-671 cells exhibited characteristic dendritic processes and expressed NFPs (NFP68, NFP160, and NFP200), parvalbumin (calcium-binding protein), and neuron-specific enolase, as well as a small amount of vimentin and desmin.
|
8780893 |
1996 |
Adult Rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In contrast to RD cells that expressed preferentially myoid and not neurofilament proteins (NFPs) upon treatment with UDP-4, differentiated RD/TE-671 cells exhibited characteristic dendritic processes and expressed NFPs (NFP68, NFP160, and NFP200), parvalbumin (calcium-binding protein), and neuron-specific enolase, as well as a small amount of vimentin and desmin.
|
8780893 |
1996 |
Adenocarcinoma of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
An alternatively spliced mRNA for the calcium-binding protein calretinin (CR) is present in the colon adenocarcinoma cell line WiDr.
|
8864572 |
1996 |
Alzheimer Disease, Late Onset
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Calmodulin is a calcium binding protein codified by three genes, one of them (CALM3) maps to chromosome 19, nearby a gene, apoE, associated with late onset AD.
|
9237482 |
1997 |
Malignant neoplasm of breast
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
The calcium-binding protein S100A2 is expressed in normal breast tissue but downregulated during breast cancer progression.
|
9481475 |
1997 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
The calcium-binding protein S100A2 is expressed in normal breast tissue but downregulated during breast cancer progression.
|
9481475 |
1997 |
Neoplasm Metastasis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
|
9703888 |
1998 |
Malignant Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
|
9703888 |
1998 |
Primary malignant neoplasm
|
0.030 |
Biomarker
|
group |
BEFREE |
S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis.
|
9703888 |
1998 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Northern blot analysis revealed that the level of mRNA for caltractin was higher in breast carcinoma than in corresponding normal tissue in all cases tested (5/5).
|
9824621 |
1998 |
Malignant Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
Overexpression of caltractin gene in tumor-infiltrating lymphocytes.
|
9824621 |
1998 |
Malignant neoplasm of stomach
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Stomach Carcinoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
leiomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Adult Leiomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Childhood Leiomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Moreover, high-level expression of the gene for caltractin was also recognized in other malignant tumors, such as hepatocellular carcinoma (HCC), gastric cancer and leiomyosarcoma.
|
9824621 |
1998 |
Graves Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
|
10052680 |
1999 |
Myositis
|
0.010 |
Biomarker
|
disease |
BEFREE |
A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin.
|
10052680 |
1999 |